title: Role of myocardial revascularization in sudden cardiac death.
abstract: Extensive atherosclerotic coronary artery disease is by far the most common pathological finding in patients with sudden cardiac death, and acute myocardial ischemia is often a contributing factor. Clinical trials using beta-blockers in postinfarction patients and bypass coronary artery surgery in patients with stable coronary artery disease have demonstrated a reduction in both sudden and total cardiac mortality after intervention. Information concerning the presence and extent of coronary artery disease, global and regional ventricular function, the presence or absence of ventricular aneurysms, and whether or not ischemia is inducible influences therapeutic management. Myocardial revascularization should be considered a primary therapy in patients with critical coronary artery stenosis, significant regions of myocardium at risk, and no inducible ventricular arrhythmias at electrophysiological testing. In patients with inducible polymorphic ventricular tachycardia or ventricular fibrillation, postoperative testing is essential, since only 50% will be suppressed by coronary artery surgery alone. In patients with inducible sustained monomorphic ventricular tachycardia and scars due to prior myocardial infarction, surgical revascularization alone will usually not be sufficient to prevent postoperative induction of the same arrhythmia. There are no data to support percutaneous transluminal coronary angioplasty as the sole therapy for post-sudden death patients who have inducible ventricular tachycardia or ventricular fibrillation on electrophysiological testing.
authors.affiliation: Division of Cardiology, University of Texas Health Science Center, San Antonio 78284-7872.
authors.forename: R A
authors.initials: RA
authors.lastname: O'Rourke
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000150:complications / Q000453:epidemiology; D016757:Death, Sudden, Cardiac / Q000209:etiology / Q000517:prevention & control*; D006323:Heart Arrest / Q000150:complications / Q000628:therapy; D006331:Heart Diseases / Q000150:complications / Q000175:diagnosis / Q000601:surgery; D006801:Humans; D015994:Incidence; D009204:Myocardial Revascularization; D015995:Prevalence